Nicotinic Acetylcholine Alpha 6 Beta 2 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Nicotinic Acetylcholine Alpha-6/Beta-2 Receptor Neurons are neurons expressing the nAChR α6β2 receptor, a member of the Nicotinic acetylcholine receptor family. These receptor neurons play crucial roles in dopamine release modulation, motor control and are implicated in various neurological and neurodegenerative conditions. [1]
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000169 | type B pancreatic cell |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000169 | type B pancreatic cell | Medium |
| Cell Ontology | CL:0000197 | sensory receptor cell | Medium |
| Cell Ontology | CL:0000789 | alpha-beta T cell | Medium |
| Property | Value |
|---|---|
| Receptor Type | nAChR α6β2 |
| Family | Nicotinic acetylcholine |
| Signaling Mechanism | Ligand-gated ion channel, selective for dopamine neurons |
| Primary Location | Substantia nigra pars compacta, striatum, VTA |
Nicotinic Acetylcholine Alpha-6/Beta-2 Receptor Neurons are involved in Dopamine release modulation, motor control. These neurons express the nAChR α6β2 receptor which ligand-gated ion channel, selective for dopamine neurons. The receptor's location in substantia nigra pars compacta, striatum, vta allows it to modulate neurotransmission and cellular signaling in key brain regions.
The nAChR α6β2 receptor signals through ligand-gated ion channel, selective for dopamine neurons. This mechanism allows rapid or modulatory responses depending on the cellular context and co-expression of other receptors.
Implicated in Parkinson's disease, dyskinesias. Understanding the role of these receptor neurons provides insight into potential therapeutic targets for these conditions.
The nAChR α6β2 receptor is a target for drug development in:
Neurological disorders
Neuropsychiatric conditions
Neurodegenerative diseases
Receptor Neurons
Neurotransmitter Systemsmechanisms/cholinergic-hypothesis-ad)
Nicotinic acetylcholine Signaling
The study of Nicotinic Acetylcholine Alpha 6 Beta 2 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.